Abstract
Among women with a mutation in BRCA1 or BRCA2, the risk of breast cancer is high, but it may be modified by exogenous and endogenous factors. There is concern that exposure to carcinogens in cigarette smoke may increase the risk of cancer in mutation carriers. We conducted a matched case–control study of 2,538 cases of breast cancer among women with a BRCA1 (n = 1,920) or a BRCA2 (n = 618) mutation. One non-affected mutation carrier control was selected for each case, matched on mutation, country of birth, and year of birth. Odds ratios were calculated using conditional logistic regression, adjusted for oral contraceptive use and parity. Ever-smoking was not associated with an increased breast cancer risk among BRCA1 carriers (OR = 1.09; 95% CI 0.95–1.24) or among BRCA2 carriers (OR = 0.81; 95% CI 0.63–1.05). The result did not differ when cases were restricted to women who completed the questionnaire within two years of diagnosis. A modest, but significant increase in risk was seen among BRCA1 carriers with a past history of smoking (OR = 1.27; 95% CI 1.06–1.50), but not among current smokers (OR = 0.95; 0.81–1.12). There appears to be no increase in the risk of breast cancer associated with current smoking in BRCA1 or BRCA2 carriers. There is a possibility of an increased risk of breast cancer among BRCA1 carriers associated with past smoking. There may be different effects of carcinogens in BRCA mutation carriers, depending upon the timing of exposure.
Similar content being viewed by others
Abbreviations
- BRCA1:
-
Breast cancer susceptibility gene 1
- BRCA2:
-
Breast cancer susceptibility gene 2
- OR:
-
Odds ratio
- CI:
-
Confidence interval
- DNA:
-
Deoxyribonucleic acid
- RR:
-
Relative risk
- HR:
-
Hazard ratio
References
Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1- mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56:256–271
Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130
Chen S, Iversen ES, Friebel T et al (2006) Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol 24:863–871
Ghadirian P, Lubinski J, Lynch H et al (2004) Smoking and the risk of breast cancer among carriers of BRCA mutations. Int J Cancer 110:413–416
Brunet JS, Ghadirian P, Rebbeck TR et al (1998) Effect of smoking on breast cancer in carriers of mutant BRCAI or BRCA2 genes. JNCI 90:761–766
Breast Cancer Family Registry; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (Australasia); Ontario Cancer Genetics Network (Canada) (2007) Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years. Breast Cancer Res Treat (Epub ahead of print)
Gronwald J, Byrski T, Huzarski T et al (2006) Influence of selected lifestyle factors on breast and ovarian cancer in BRCA1 mutation carriers from Poland. Breast Cancer Res Treat 95:105–109
Nkondjock A, Robidoux A, Paredes Y et al (2006) Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians. Breast Cancer Res Treat 98:285–294
Collia S, Kantoff PW, Neuhausen SL et al (2006) The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. Carcinogenesis 27:599–605
Couch FJ, Cerhan JR, Vierkant RA et al (2001) Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. Cancer Epidemiol Biomarkers Prev 10:327–332
Reynolds P, Hurley S, Goldberg D et al (2004) Active smoking, passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst 96:29–37
Bennicke K, Conrad C, Sabrae S et al (1995) Cigarette smoking and breast cancer. Br Med J 310:1431–1432
Braga C, Negri E, La Vecchia C et al (1996) Cigarette smoking and risk of breast cancer. Eur J Cancer Prev 5:159–164
Lash TL, Aschengrau A (1999) Active and passive cigarette smoking and the occurrence of breast cancer. Am J Epidemiol 149:5–12
Marcus PM, Newman B, Millikan RC et al (2000) The associations of adolescent cigarette smoking, alcohol beverage consumption, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States). Cancer Causes Control 11:271–278
Johnson KC, Hu J, Mao Y (2000) Passive and active smoking and breast cancer risk in Canada, 1994–97. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control 11:211–221
Band PR, Le ND, Fang R et al (2002) Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 360:1044–1049
Kropp S, Chang-Claude J (2002) Active and passive smoking and risk of breast cancer by age 50 years among German women. Am J Epidemiol 156:616–626
Egan KM, Stampfer MJ, Hunter D et al (2002) active and passive smoking in breast cancer: prospective results from the Nurses’ Health Study. Epidemiology 13:138–145
Hamajima N, Hirose K, Tajima K et al (2002) Alcohol, tobacco, and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 87(11):1234–1245
Lawlor DA, Ebrahim S, Smith GD (2004) Smoking before the birth of a first child is not associated with increased risk of breast cancer: findings from the British Women Heart and Health Cohort Study and a meta-analysis. Br J Cancer 91:512–518
Johnson JC (2005) Accumulating evidence on passive and active smoking and breast cancer risk. Int J Cancer 117:619–628
Terry PD, Rohan TE (2002) Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev 11:953–971
Al-Delaimy WK, Cho E, Chen W et al (2004) A prospective study of smoking and risk of breast cancer in young adult women. Cancer Epidemiol Biomarkers Prev 13:398–404
Gram IT, Braaten T, Terry PD et al (2005) Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomarkers Prev 14:61–66
London SJ, Colditz GA, Stampfer MJ et al (1989) Prospective study of smoking and the risk of breast cancer. J Natl Cancer Inst 81:1625–1631
Morabia A, Bernstein M, Ruiz J et al (1998) Relation of smoking to breast cancer by estrogen receptor status. Int J Cancer 75:339–342
Obana H, Hori S, Kashimoto T, Kunita N (1981) Polycyclic aromatic hydrocarbons in human fat and liver. Bull Environ Contam Toxicol 27:23–27
IARC (1986) Tobacco smoking. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. IARC Sci Publ 38, IARC Lyon, France, pp 1–397
el-Bayoumy K (1992) Environmental carcinogens that may be involved in human breast cancer etiology. Chem Res Toxicol 5:585–590
Morris JJ, Seifter E (1992) The role of aromatic hydrocarbons in the genesis of breast cancer. Med Hypotheses 38:177–184
Hoffman D, Hoffman I, el-Bayoumy K (2001) The less harmful cigarette: a controversial issue. A tribute to Ernst L Wynder. Chem Res Toxicol 14:767–790
Phillips DH, Martin FL, Grover PL, Williams JA (2001) Toxicological basis for a possible association of breast cancer with smoking and other sources of environmental carcinogens. J Women’s Cancer 2:9–16
Perera FP, Estabrook A, Hewer A (1995) Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev 4:233–238
Kaufman DW, Slone D, Rosenberg L, Miettinen OS, Shapiro S (1980) Cigarette smoking, age at natural menopause. Am J Public Health 70:420–422
Williams AR, Weiss NS, Ure CI et al (1982) Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women. Obstet Gynecol 60:695–699
MacMahon B, Trichopoulos D, Cole P et al (1982) Cigarette smoking and urinary estrogens. N Engl J Med 307:1062–1065
Baron JA, La Vecchia C, Levi F (1990) The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gyneco1 162:502–514
Lesko SM, Rosenberg L, Kaufman DW et al (1985) Cigarette smoking and the risk of endometrial cancer. N Engl J Med 313:593–596
Hosey AM, Gorski JJ, Murray MM et al (2007) Molecular basis for estrogen receptor α deficiency in BRCA1-linked breast cancer. J Natl Cancer Inst 99:1683–1694
Acknowledgement
SNL was supported by grant R01 CA744175.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Other members of the Hereditary Breast Cancer Clinical Study Group: Olufunmilayo Olopade, Shelly Cummings, Fergus Couch, Barry Rosen, Dominique Stoppa-Lyonnet, Ruth Gershoni-Baruch, David Horsman, Teresa Wagner, Howard Saal, Ellen Warner, Wendy Meschino, Kenneth Offit, Amber Trivedi, Michael Osborne, Dawna Gilchrist, Charis Eng, Jeffrey Weitzel, Wendy McKinnon, Marie Wood, Christine Maugard, Barbari Pasini, Peter Ainsworth, Kevin Sweet, Boris Pasche, Beth Karlan, Raluca N. Kurz, Anna Tulman, Ed Lemire, Jane Mclennan, Gareth Evans, Tomas Byrski, Tomas Huzarski, Jacek Gronwald, Bohdan Gorski, Eitan Friedman, Andrea Eisen, Mary Daly, Judy Garber, Sofia Merajver.
Rights and permissions
About this article
Cite this article
Ginsburg, O., Ghadirian, P., Lubinski, J. et al. Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update. Breast Cancer Res Treat 114, 127–135 (2009). https://doi.org/10.1007/s10549-008-9977-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-008-9977-5